Modern life sciences companies are generating mission-critical data with increasing volume, velocity, and variety and extending to new domains, like the cloud. All the while, global regulations like GDPR and CCPA, and threats from ransomware attacks
complicate an already heterogeneous landscape. What is a life sciences organization to do? In this webinar, several leading ﬁgures in the life sciences IT domain will discuss data governance strategies and proven tools to tackle an increasingly
complex set of risks for the industry.
In this webinar you will learn:
- How speciﬁc data privacy regulations are impacting life science companies and the corresponding risks
- Pragmatic approaches and tools, like machine learning, that can support compliance and improved data management
- Methods of facilitating data protection, including ransomware and insider threat protection, for mission-critical data relevant to drug or device development
- Strategies for managing data in hybrid environments – on-premise and in the cloud
IT Director, Vice President of IT, CIO, CTO, Compliance Officer, Governance, Security Professional, Scientist, Researcher, Program Manager, Scientific Leader, Clinical Trial Operations, Clinical Trial Management, Data Scientist, Quality Assurance,
Regulatory Affairs, Data Management
Data Governance: What It’s Not and What It Can Be - An Opportunity for Bio-IT Teams
In the Wild West that was the R&D landscape, the phrase “data governance” used to spark fear and send scientists
scrambling for ways to avoid any and all of the presumed restrictions, and therefore delays, that such a process could introduce to their research. But things have changed. Today, the advent of new and emerging technologies is driving up the
demand for sensible solutions that protect the integrity of data without sacrificing usability through the full drug development lifecycle. In this talk, learn more about the common challenges teams are facing in relation to data control measures—and
why you need not fear them with the right strategies in place.
Michael oversees the executive management of RCH, including the company’s overall strategic direction, and brings more than 25 years of experience to his role. His primary responsibilities are business development, sales and marketing. Michael has been an officer since 2006 and was instrumental in the evolution of the company business model. During this time, RCH has experienced significant market and revenue growth in Life Sciences and Healthcare industries.
Alok Tayi, PhD
Vice President, Life Sciences
Data Governance at the Pace of Modern Drug Development
Modern life sciences companies demand that scientific activities move rapidly. However, in today’s world, speed is often hampered by risks to their data. Ransomware attacks, insider threats and non-compliance with data privacy regulations are examples of such obstacles. Fortunately, recent advancements in technology and machine learning have afforded new ways to mitigate risk without compromising ease-of-use or cost of ownership. In this presentation, we will cover how high-growth companies are facilitating intelligent data governance and protection, while maintaining effective user collaboration.
Alok is the Vice President of Life Sciences at Egnyte where he is responsible for building and executing the company's strategy for the life sciences market. Before joining Egnyte, Alok was a Y Combinator-backed entrepreneur and started two vertical software-as-a-service companies. Prior to his career in software, Alok spent over 15 years as a scientist: he took part in postdoctoral work at Harvard University with George Whitesides, and has published papers in Nature and Nature Chemistry. Alok holds a PhD from Northwestern University and BS from Cornell University.
Allison Proffitt is a science writer with a background in biology and chemistry, research experience in cancer biology, and an expanding repertoire in biotech, AI, and battery chemistry. She serves as the editorial director for the Healthtech Publishing media group, a growing collection of online news sites. In addition to Bio-IT World, her work has been published by Nature Biotech, Chemical & Engineering News, and the Economist Intelligence Unit. She has a bachelor’s degree in communication of science, engineering, and technology from Vanderbilt University and a Master’s degree in science and medical writing from Johns Hopkins University.
Egnyte is the only secure content platform built specifically for business. With over 14,000 customers worldwide, in a variety of different vertical markets, Egnyte delivers secure content collaboration, compliant data protection and simple infrastructure modernization; all through a single SaaS platform. Founded in 2007, Egnyte is a privately held company with headquarters in Mountain View, CA, and offices in Raleigh, NC, Spokane, WA, London, and Poland. Investors include Google Ventures, Kleiner Perkins, Caufield & Byers, and Goldman Sachs.
Cost: No Cost!
Schedule conflict? Register and you'll receive a copy of the recording!